
Inhalation Sciences Investor Relations Material
Latest events

Study Result
Inhalation Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Inhalation Sciences
Access all reports
Inhalation Sciences Sweden AB (ISAB) develops and markets laboratory equipment designed for inhalation research. The company’s primary offerings include systems such as PreciseInhale, which allows scientists to measure how inhaled particles behave in the lungs, and DissolvIt, a tool for in vitro simulation of particle dissolution and absorption in the lung epithelium. Their portfolio also includes specialized modules like XposeALI, for 3D cell exposure, and other equipment used in preclinical testing of inhalation drugs and toxicity studies. Inhalation Sciences serves industries involved in respiratory medicine, toxicology, and aerosol science. The company is headquartered in Huddinge, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
ISAB
Country
🇸🇪 Sweden